// App-Quantinova.ai

TCT-569 : Lower mortality after clinically significant bleeding in patients treated with reversible P2Y12 agent Ticagrelor: A comparative, all-comers, prospective, 2-year follow up study in patients treated with invasive strategy after acute coronary syndrome

Researchers

Presenter

  • Girish Viswanathan

Principal Investigators

  • James Russel

  • Nadia Dullaghan

  • Sotirios Dardas

  • Amit Taneja

  • Shabnam Venkat

Medical Centers

  • South West Cardiothoracic centre, Derriford Hospital, Plymouth, United Kingdom

  • Plymouth University, Plymouth, United Kingdom

  • University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Cardiac arrest

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Prasugrel

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved